Healthcare -
Biotechnology - NASDAQ - US
$ 1.16
-0.431 %
$ 1.47 M
Market Cap
-0.08
P/E
KTTA - COST OF REVENUE
Cost of Revenue KTTA - Pasithea Therapeutics Corp.
648 K
LAST VALUE
512.68%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR